Display Settings:

Format

Send to:

Choose Destination
    Immunol Res. 2010 Jul;47(1-3):216-27.

    Hepatitis C virus evasion of adaptive immune responses: a model for viral persistence.

    Source

    Johns Hopkins University School of Medicine, Rangos Building, Suite 536, Baltimore, MD 21205, USA.

    Erratum in

    • Immunol Res. 2010 Jul;47(1-3):285.

    Abstract

    Hepatitis C virus (HCV) infects over 170 million people worldwide and is a leading cause of cirrhosis and hepatocellular carcinoma. Approximately 20% [corrected] of those acutely infected clear the infection, whereas the remaining 80% [corrected] progress to chronic infection. Hepatitis C thus provides a model in which successful and unsuccessful responses can be compared to better understand the human response to viral infection. Our laboratory studies the strategies by which HCV evades the adaptive immune response. This review describes the impact of viral mutation on T cell recognition, the role of cell surface inhibitory receptors in recognition of HCV, and the development of antibodies that neutralize HCV infection. Understanding what constitutes an effective immune response in the control of HCV may enable the development of prophylactic and therapeutic vaccines for HCV and other chronic viral infections.

    PMID:
    20066508
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC2910517
    Free PMC Article

    Images from this publication.See all images (1) Free text

    Figure 1

      Supplemental Content

      Icon for Springer Icon for PubMed Central

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk